We can assist you in addressing questions like:

 

• What are the costs and benefits of continued use, or restricting the use, of a substance?

• How do we value human health and the environment?

• What are the costs of compliance for a company or sector?

• Is the cost of regulating a chemical disproportionate?

• What are the best regulatory instruments for managing risks from a substance?

• How do value the importance of a substance in the EU?

 

What We Do

​

Our chemicals policy service benefits from our extensive experience with assessing impacts on human health, the environment, industry, and wider society.

 

We utilise assessment frameworks such as impact assessments, cost-benefit analysis, risk management option analysis, analysis of alternatives, and more.

 

Together with our technical partners we support clients through entire regulatory processes. We develop complete REACH Authorisations and Restrictions dossiers and have unique experience carrying out Risk Management Option Analyses (RMOAs) using a multi-criteria approach to compare different regulatory actions to mitigate risks from specific chemicals.

​

Examples of Our Work

​

Our work spans a wide range of chemicals policies, including:

​

• REACH (Authorisations and Restrictions)

• CLP (including CLH)

• CMRD and CAD (including OELs)

• Water Framework Directive (WFD)

• Stockholm Convention on POPs

• Biocidal Product Regulation (BPR)

• Restriction of Hazardous Substances (RoHS)  Directive

• Other national, regional and global policy initiatives (e.g., TSCA)

​

Some of our clients for this service include:

 

Department for Environment, Food & Rural Affairs (Defra) and chemicals agencies in two other European countries, Environment Agency (England), European Commission, European Chemicals Agency, Nickel Institute, Cadmium REACH Consortium, Vlisco, Cobalt REACH Consortium and OLON Spa.

 

Contact Person: Thea Sletten